Kenvue says that Thibaut Mongon is stepping down as its CEO as the maker of Listerine and Band-Aid brands continues with a ...

Kenvue said Monday that its board was taking steps to realize shareholder value and allow the company to “reach its full ...

All that culminated on Monday with the abrupt resignation of Kenvue CEO Thibaut Mongon, his replacement by board director Kirk Perry on an interim basis, and the confirmation that Kenvue is ...

American consumer health company Kenvue's Board of Directors announced new actions to unlock shareholder value and an interim ...

When Magic Johnson announced his HIV diagnosis, it shocked the world and forever changed the conversation around health, ...

Johnson & Johnson offers stability with 62 years of dividend growth and a 3.44% yield. Click for why JNJ is undervalued and poised for potential 65% upside.

A new exposé delves into the safety and marketing practices of the iconic brand.

Daniel Loeb's Third Point has acquired a stake in Kenvue, the $44 billion consumer healthcare company behind brands like Band-Aid and Tylenol. This move comes amid pressure from activist investors ...

At least half a dozen customers who purchased Band-Aid products have filed a class-action lawsuit against Johnson & Johnson and global consumer health company Kenvue for selling bandages that ...

Johnson & Johnson is capturing strong demand across its pharmaceutical and medtech portfolio. New product launches and an extensive pipeline of candidate drugs support a positive growth outlook.

The maker of Tylenol, Listerine, Neutrogena, Band-Aids and Benadryl plans a global headquarters in New Jersey with over 3,000 scientists and other employees over the next few years. Kenvue — a ...

A class action complaint filed in federal court this week against Johnson & Johnson alleges that some Band-Aid products contain "forever chemicals," according to a study commissioned by consumer ...